Developer docs
API playgroundTry for free, no card

Search company profiles

Celoxica

Full company profile

uuid0009mck

Namestring
Celoxica
Legal namestring
Celoxica Limited
Websiteurl
celoxica.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Celoxica is a UK-headquartered, privately-held vendor of FPGA-based ultra-low latency trading infrastructure serving the global capital markets electronic-trading community. Its platform is composed of three integrated core products: QDS (FPGA-based feed handlers delivering normalised market data with instrument filtering, line arbitrage, and full depth-of-book reconstruction), MAG (an in-line pre-trade risk management and DMA platform offering single-digit microsecond FIX latency, hundreds-of-nanoseconds Native latency, and 15-C3 / MiFID II compliance), and GXA (venue gateways providing normalised APIs, session management, load balancing, and TCP Direct order execution). Together they form a full tick-to-trade stack covering market data ingestion, risk controls, and order routing across equities, futures, options, and fixed income, supported at over 60 exchanges, brokers, and liquidity venues worldwide.

The company serves two primary customer segments — buy-side firms (hedge funds, quantitative traders, proprietary trading firms) and sell-side institutions (banks and brokers) — through a direct enterprise field-sales motion with regional coverage in London (HQ), New York (Americas), Sydney (APAC), and Paris (engineering). Revenue is generated via managed-service engagements delivered in co-located hosting environments, encompassing implementation, onboarding, EDC support, and ongoing platform monitoring, alongside recurring platform access for MAG, GXA, and QDS. Pricing is quote-based and not publicly disclosed. Celoxica is ISO 27001 certified, won the TradingTech Insight Awards Europe 2026 "Best Pre-trade Risk Provider" recognition, and is led by an executive team drawn from Instinet, Merrill Lynch, Goldman Sachs, Deutsche Bank, Morgan Stanley, NYSE Euronext, and Reuters.

Short descriptiontext

Celoxica provides FPGA-based ultra-low latency market data (QDS), pre-trade risk and DMA (MAG), and order execution gateways (GXA) as an integrated tick-to-trade platform for global hedge funds, proprietary traders, and sell-side banks and brokers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ultra-low latency trading, FPGA market data, pre-trade risk management, order execution gateways, systematic trading infrastructure
NAICS code3 codes
  • Securities and Commodity Exchanges52321
  • Investment Banking and Securities Intermediation52315
  • Investment Banking and Securities Intermediation523150
SIC code1 code
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Low-Latency Trading Technology
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Managed Trading Infrastructure Services
TypeManaged Services
Description

Full-service ULL trading solutions including low-latency products, associated infrastructure services, implementation, client onboarding, system upgrades, EDCs, and platform monitoring. Revenue generated through managed services delivered in fully hosted, co-located environments.

celoxica.com
2Technology Licensing and Platform Access
TypeSubscription Recurring
Description

Access to MAG risk management platform, GXA execution gateways, and QDS market data products, provided as integrated solutions rather than standalone products.

celoxica.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1MAG
Description

Pre-trade risk management and DMA platform providing ultra-low latency risk and execution services with extensive operational management, GUI front end, Drop Copy interface, API risk integration, and full monitoring services.

celoxica.com
+2 more records
Core offering1 text field

Celoxica provides an integrated ultra-low latency trading platform comprising three products — QDS market data feed handlers, MAG pre-trade risk management and direct market access, and GXA order execution gateways — delivered as a full-service, co-located managed trading stack for buy-side and sell-side systematic trading clients across global equities, derivatives and fixed income markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Single-digit wire-to-wire latency for FIX and hundreds of nanoseconds for Native protocols
+2 more records
Product overview1 text field

Celoxica provides a unified platform of three integrated core products for ultra-low latency trading: MAG (Pre-trade Risk Management and DMA), GXA (Gateways/Order Execution), and QDS (Market Data/Feed Handlers). These products work together to deliver a full-service trading solution from tick to trade, supporting the complete systematic trading lifecycle across market data, risk management, and order execution for buy and sell side clients globally.

Product and service3 records
1MAG (Pre-trade Risk Management and DMA)
CategoryPre-trade Risk Management and DMA Platform
Description

In-Line Risk Management and Order Execution platform providing ultra-low latency pre-trade risk controls and direct market access for brokers and buy-side trading firms across multiple asset classes including futures, equities, rates and options. Supports single-digit wire-to-wire latency for FIX, hundreds of nanoseconds for Native protocols, EDC support, high availability, and full compliance with 15-C3 and MiFID II.

2GXA (Gateways, Order Execution)
CategoryOrder Execution Gateways
Description

Accelerated Order Entry solutions providing deterministic performance across a wide range of exchanges and trading venues via a normalised API supporting multiple asset classes, session management, order balancing, FIX parsing, TCP Direct connectivity and full recovery.

3QDS (Ultra Low Latency Market Data)
CategoryUltra-Low Latency Market Data Feed Handlers
Description

FPGA-based Feed Handler technology delivering normalised market data with instrument filtering, line arbitrage, full depth order books, normalisation, fully automated recovery and multi-channel DMA, deployed on the same server as client trading strategies via a C++ API to produce deterministic ultra-low latency performance.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Order management and execution platform widely used by hedge funds and asset managers. Adjacent competitor for trading workflow layer where Celoxica's clients sit.

TypeDirect peer
Description

Provides ultra-low latency pre-trade risk management and order routing technology for derivatives and equities markets. Competes head-to-head with Celoxica's MAG and GXA products in the broker and exchange space.

TypeBroad incumbent
Description

Large capital markets technology provider with multiple trading, risk, and connectivity products. Sells into the same bank and broker buyers Celoxica targets, often as bundled offering.

4Enfusion (now Clearwater Analytics)
TypeBroad incumbent
Description

Cloud-native investment management platform including order/EMS capabilities; competes adjacent to Celoxica in serving the same hedge fund and prop trading buyer base, though with software rather than FPGA architecture.

TypeDirect peer
Description

FPGA-based market data normalization and order execution for equities and derivatives. Direct technology competitor in FPGA feed handling and execution, serving similar buy-side and sell-side clients.

TypeDirect peer
Description

FPGA-accelerated trading solutions including feed handlers, pre-trade risk, and execution for global exchanges. Direct technology peer competing on the same FPGA deterministic-latency value proposition.

TypeDirect peer
Description

Provider of FPGA-accelerated market data feed handlers, pre-trade risk, and execution gateways for global capital markets. Closest direct competitor to Celoxica's QDS/MAG/GXA stack, now part of FactSet.

TypeDirect peer
Description

Ultra-low latency market data and order execution platform designed for systematic trading firms. Direct competitor in co-located feed handling and execution gateway products.

TypeBroad incumbent
Description

Broad post-trade and connectivity platform for capital markets, including low-latency order routing and FIX gateways. Larger incumbent with broader portfolio, competing in execution gateway and connectivity tiers.

TypeBroad incumbent
Description

Global capital markets technology vendor offering trading, risk, and post-trade infrastructure. Larger incumbent that competes in execution, risk, and market data tiers served by Celoxica.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Celoxica

Low-Latency Trading Technologyceloxica.com

Celoxica provides FPGA-based ultra-low latency market data (QDS), pre-trade risk and DMA (MAG), and order execution gateways (GXA) as an integrated tick-to-trade platform for global hedge funds, proprietary traders, and sell-side banks and brokers.

What Celoxica does

Celoxica is a UK-headquartered, privately-held vendor of FPGA-based ultra-low latency trading infrastructure serving the global capital markets electronic-trading community. Its platform is composed of three integrated core products: QDS (FPGA-based feed handlers delivering normalised market data with instrument filtering, line arbitrage, and full depth-of-book reconstruction), MAG (an in-line pre-trade risk management and DMA platform offering single-digit microsecond FIX latency, hundreds-of-nanoseconds Native latency, and 15-C3 / MiFID II compliance), and GXA (venue gateways providing normalised APIs, session management, load balancing, and TCP Direct order execution). Together they form a full tick-to-trade stack covering market data ingestion, risk controls, and order routing across equities, futures, options, and fixed income, supported at over 60 exchanges, brokers, and liquidity venues worldwide.

The company serves two primary customer segments — buy-side firms (hedge funds, quantitative traders, proprietary trading firms) and sell-side institutions (banks and brokers) — through a direct enterprise field-sales motion with regional coverage in London (HQ), New York (Americas), Sydney (APAC), and Paris (engineering). Revenue is generated via managed-service engagements delivered in co-located hosting environments, encompassing implementation, onboarding, EDC support, and ongoing platform monitoring, alongside recurring platform access for MAG, GXA, and QDS. Pricing is quote-based and not publicly disclosed. Celoxica is ISO 27001 certified, won the TradingTech Insight Awards Europe 2026 "Best Pre-trade Risk Provider" recognition, and is led by an executive team drawn from Instinet, Merrill Lynch, Goldman Sachs, Deutsche Bank, Morgan Stanley, NYSE Euronext, and Reuters.

Celoxica firmographics

Firmographics
Name
Celoxica
Legal name
Celoxica Limited
Website
https://celoxica.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
51–100 employees
Short description
Celoxica provides FPGA-based ultra-low latency market data (QDS), pre-trade risk and DMA (MAG), and order execution gateways (GXA) as an integrated tick-to-trade platform for global hedge funds, proprietary traders, and sell-side banks and brokers.
Ownership category
akta.pro rank

Where Celoxica is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Celoxica business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Managed Trading Infrastructure Services: Full-service ULL trading solutions including low-latency products, associated infrastructure services, implementation, client onboarding, system upgrades, EDCs, and platform monitoring. Revenue generated through managed services delivered in fully hosted, co-located environments.
  2. Technology Licensing and Platform Access: Access to MAG risk management platform, GXA execution gateways, and QDS market data products, provided as integrated solutions rather than standalone products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Celoxica product offering

Product offering

Core offering

Celoxica provides an integrated ultra-low latency trading platform comprising three products — QDS market data feed handlers, MAG pre-trade risk management and direct market access, and GXA order execution gateways — delivered as a full-service, co-located managed trading stack for buy-side and sell-side systematic trading clients across global equities, derivatives and fixed income markets.

Product overview

Celoxica provides a unified platform of three integrated core products for ultra-low latency trading: MAG (Pre-trade Risk Management and DMA), GXA (Gateways/Order Execution), and QDS (Market Data/Feed Handlers). These products work together to deliver a full-service trading solution from tick to trade, supporting the complete systematic trading lifecycle across market data, risk management, and order execution for buy and sell side clients globally.

Differentiator

Problem solved

Functional benefit

Brands

  • MAG: Pre-trade risk management and DMA platform providing ultra-low latency risk and execution services with extensive operational management, GUI front end, Drop Copy interface, API risk integration, and full monitoring services.
  • GXA
  • QDS

Products and services

  • MAG (Pre-trade Risk Management and DMA) In-Line Risk Management and Order Execution platform providing ultra-low latency pre-trade risk controls and direct market access for brokers and buy-side trading firms across multiple asset classes including futures, equities, rates and options. Supports single-digit wire-to-wire latency for FIX, hundreds of nanoseconds for Native protocols, EDC support, high availability, and full compliance with 15-C3 and MiFID II.
  • GXA (Gateways, Order Execution) Accelerated Order Entry solutions providing deterministic performance across a wide range of exchanges and trading venues via a normalised API supporting multiple asset classes, session management, order balancing, FIX parsing, TCP Direct connectivity and full recovery.
  • QDS (Ultra Low Latency Market Data) FPGA-based Feed Handler technology delivering normalised market data with instrument filtering, line arbitrage, full depth order books, normalisation, fully automated recovery and multi-channel DMA, deployed on the same server as client trading strategies via a C++ API to produce deterministic ultra-low latency performance.

Quantifiable outcome

  • Single-digit wire-to-wire latency for FIX and hundreds of nanoseconds for Native protocols
  • +2 more outcomes

Companies that use Celoxica

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Celoxica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Celoxica partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Celoxica competitors and assessment

Company assessment

Broad incumbents

  • SS&C Eze: Order management and execution platform widely used by hedge funds and asset managers. Adjacent competitor for trading workflow layer where Celoxica's clients sit.
  • ION Group: Large capital markets technology provider with multiple trading, risk, and connectivity products. Sells into the same bank and broker buyers Celoxica targets, often as bundled offering.
  • Enfusion (now Clearwater Analytics): Cloud-native investment management platform including order/EMS capabilities; competes adjacent to Celoxica in serving the same hedge fund and prop trading buyer base, though with software rather than FPGA architecture.
  • Itiviti (now Broadridge): Broad post-trade and connectivity platform for capital markets, including low-latency order routing and FIX gateways. Larger incumbent with broader portfolio, competing in execution gateway and connectivity tiers.
  • FIS (Fidelity National Information Services): Global capital markets technology vendor offering trading, risk, and post-trade infrastructure. Larger incumbent that competes in execution, risk, and market data tiers served by Celoxica.

Direct peers

  • Options IT: Provides ultra-low latency pre-trade risk management and order routing technology for derivatives and equities markets. Competes head-to-head with Celoxica's MAG and GXA products in the broker and exchange space.
  • NovaSparks: FPGA-based market data normalization and order execution for equities and derivatives. Direct technology competitor in FPGA feed handling and execution, serving similar buy-side and sell-side clients.
  • Algo-Logic Systems: FPGA-accelerated trading solutions including feed handlers, pre-trade risk, and execution for global exchanges. Direct technology peer competing on the same FPGA deterministic-latency value proposition.
  • Exegy: Provider of FPGA-accelerated market data feed handlers, pre-trade risk, and execution gateways for global capital markets. Closest direct competitor to Celoxica's QDS/MAG/GXA stack, now part of FactSet.
  • Redline Trading Solutions: Ultra-low latency market data and order execution platform designed for systematic trading firms. Direct competitor in co-located feed handling and execution gateway products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Celoxica social profiles

Digital presence

Celoxica compliance and trust

Trust signal

Compliance1 record

Celoxica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Celoxica leadership team

Management profile

Number of profiles

Profiles8 records

Celoxica funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Celoxica M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celoxica

What does Celoxica do?

Celoxica provides an integrated ultra-low latency trading platform comprising three products — QDS market data feed handlers, MAG pre-trade risk management and direct market access, and GXA order execution gateways — delivered as a full-service, co-located managed trading stack for buy-side and sell-side systematic trading clients across global equities, derivatives and fixed income markets.

Is Celoxica a public or private company?

Celoxica is a private company. It is classified as venture growth investor backed and is currently operating.

When was Celoxica founded?

Celoxica was founded in 1996. It employs 51 to 100 people.

Where is Celoxica based?

Celoxica is headquartered in London, United Kingdom, in the Europe region.

How does Celoxica make money?

Two revenue lines are on record. Managed Trading Infrastructure Services are the primary driver. The others are technology Licensing and Platform Access.

Who are Celoxica's main competitors?

Broad incumbents on record are SS&C Eze, ION Group, Enfusion (now Clearwater Analytics), Itiviti (now Broadridge) and FIS (Fidelity National Information Services). Direct peers are Options IT, NovaSparks, Algo-Logic Systems, Exegy and Redline Trading Solutions.

Does Celoxica have an API?

No public API is recorded for Celoxica.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The PayperssmartTrade acquires Celoxica to expand into listed markets | The PayperssmartTrade Technologies acquired Celoxica, a provider of ultra-low latency execution infrastructure for listed markets. The deal extends smartTrade's coverage from OTC to listed markets and gives Celoxica access to smartTrade's 250+ clients. Celoxica's client contracts and services remain unchanged.The TRADEsmartTrade strikes Celoxica deal to expand multi-asset trading capabilitiessmartTrade agreed to acquire Celoxica, an ultra-low latency execution infrastructure provider. The deal expands smartTrade's multi-asset trading solutions across OTC and listed markets, covering over 250 users globally. Celoxica's technology will be leveraged by smartTrade's clients in EMEA, the Americas, and APAC.FinanceFeedssmartTrade Buys Celoxica, Adds Execution on 80+ VenuessmartTrade Technologies acquired Celoxica, adding execution infrastructure for listed equities, futures, fixed income, and options across 80+ venues. The deal combines Celoxica's market data, access gateways, and execution engines with smartTrade's pricing and workflow products. Financial terms were not disclosed.FinextraSmartTrade acquires CeloxicasmartTrade Technologies acquired Celoxica, a provider of ultra-low latency execution infrastructure for listed markets. The deal extends smartTrade's coverage from OTC to listed markets and adds execution infrastructure to its orchestration and pricing services. Celoxica's client relationships and operations remain unchanged.Dealroom.cosmartTrade buys Celoxica to add listed-market execution speed | Dealroom NewssmartTrade Technologies acquired Celoxica, a listed-market execution infrastructure provider, for an undisclosed amount. The deal extends smartTrade's coverage from over-the-counter to listed markets and integrates Celoxica's technology with smartTrade's 250-plus clients. Celoxica's client relationships remain unchanged, with its general manager joining smartTrade's executive committee.FxnewsgroupsmartTrade expands listed markets solutions acquiring CeloxicasmartTrade Technologies acquired Celoxica, a provider of ultra-low latency execution infrastructure for listed markets. The deal extends smartTrade's coverage from OTC to listed markets and adds Celoxica's technology to smartTrade's 250+ clients. Celoxica's leadership remains unchanged, and clients gain access to smartTrade's broader ecosystem.FinSMEsCeloxica Raises £1.5M from BeringeaCeloxica, a UK-based ultra low-latency market data and order entry provider, raised £1.5M from Beringea Growth Finance. The company will use the funds to support operational growth and develop new market segments. It was established in 1996 as a spinout of Oxford University.FinSMEsCeloxica Completes $3M FundingCeloxica, a London-based ultra low latency market data provider, completed a $3M funding round led by Oxford Capital Partners. The company will use the capital to expand sales and marketing in the US and Europe and invest in technology. It also launched its Generic Book Accelerator product line for US markets.VC News DailyCeloxica Raises $3MCeloxica, a provider of ultra low latency market data and trading solutions for high frequency traders and brokers, has completed a $3 million funding round led by Oxford Capital Partners. The company plans to use the capital to expand its sales and marketing presence in the US and Europe, and to continue investment in its technology roadmap, while also launching its new Generic Book Accelerator product line for US markets. The funding comes amid ongoing margin pressures in the trading industry, with Celoxica positioning its FPGA-based solutions as a way to reduce total cost of ownership for trading firms.